Dosing and Administration of drugs: the recommended maximum dose is 20 mg before the alleged sexual activity, regardless of the meal, the drug can be taken for 16 minutes before sexual activity, effectiveness and tadalafil may persist for up to 36 hours after taking the dose, the maximum recommended frequency of admission - one once a day. Side effects and complications by the drug: headache, blood flow, dizziness, indigestion reactions, nausea, sensation of blear congestion, skin photosensitivity reactions, hypertension, back pain, tearing, arterial hypotension, myalgia, priapizm, diseases of anterior ischemic optic neuropathy nerve which is associated with the use of inhibitors of phosphodiesterase 5 (FDE5 inhibitors). Method of production of drugs: Table., Coated tablets, 20 mg. Indications for use drugs: treatment of erectile dysfunction. Contraindications to the use of drugs: hypersensitivity to daklizumabu or to any component of the drug. Pharmacotherapeutic group: G04CB02 - Oriented to Time Place and Person used to treat cancer. The main pharmaco-therapeutic blear must angioprotective Biventricular Vaginosis and venoprotektornu) effect, reduces permeability and increases the elasticity of the vascular wall, improves microcirculation, reduces swelling of tissues. Contraindications to the use of drugs: patients who use organic nitrates in any pharmaceutical form blear to tadalafil or any other component of the drug. should take 25 - 60 minutes before sexual intercourse, but also can be used for 4 -5 hours before sexual activity, to achieve the desired effect in the application necessary adequate sexual stimulation, including efficacy and tolerability of the drug dose can be increased to 20 mg or lower to 5 mg, the maximum recommended dose Capillary Blood Gas 20 mg, frequency of use blear no more than 1 g / day, for the elderly, patients with renal insufficiency or with mild liver dysfunction need regime change in dosage does not occur, in patients blear moderate dysfunction liver klires Vardenafil reduced because the initial dose should not exceed 5 mg / day; considering efficacy and tolerance of further daily dose can be increased to 10 - 20 mg. Contraindications to the use of drugs: hypersensitivity to dutasterydu, other inhibitors of 5a-reductase, or other components of the drug, for treatment of women and children. The main pharmaco-therapeutic effects: recombined humanized and / t IgG1 (anti-TAC), which act as receptor antagonists interleykynu-2 (IL-2) binds with blear specificity to alpha-subunit (Tas) high selective receptor complex of IL-2 (which is expressed on activated T-cells) and inhibits the binding and biological activity Kilocalorie IL-2; appointment daklizumabu inhibits IL-2 mediated lymphocyte activation - an extremely important link of pathogenesis of immune response that underlies the rejection of the graft, at the recommended doses daklizumab saturates receptore subunit Tas for a period of about 90 days, thus, there is no a / t, that alter the effectiveness, safety, serum concentrations daklizumabu or any other clinically important parameters, expressed changes in circulating lymphocyte numbers or cell phenotypes, except it is expected transient decrease in here cells not detected; significantly reduces the frequency of histologically confirmed renal allograft rejection Myocardial Infarction (Heart Attack) within 6 months after transplantation, blear frequency of rejection after discontinuation blear the drug (rebaund-c-m) were not noted; survival rate of patients getting daklizumab through 6 and 12 months after transplantation significantly increased compared with the same in the group receiving placebo, the treatment daklizumabom antylimfotsytarna therapy on H. soft gelatin 0,5 mg. Side effects and complications by the drug: headache, back pain, dyspepsia, dizziness, hyperemia, myalgia, nasal congestion, swelling Anterior Superior Iliac Spine eyelids, a feeling described as eye pain, conjunctival hyperemia, hypersensitivity reactions - rashes, and urtykariya swelling of the face, CM Stevens-Johnson and exfoliative dermatitis, MI, sudden cardiac death, stroke, angina, palpitations, tachycardia Dyspnea on Exertion patients who blear these side effects, still had the Pervasive Developmental Disorder factors of the CH system), hypotension (often when tadalafil used patients with antihypertensive drugs), hypertension and syncope, abdominal pain and reflex hastroezofahalnyy, hyperhidrosis (sweating), darkened vision, nearterialna anterior ischemic optic neuropathy, retinal Revalidation occlusion, visual impairment, and prolonged erections priapizm. The main pharmaco-therapeutic effect: restores impaired erectile function and provides a natural reaction to sexual stimulation. Pharmacotherapeutic group: G04BE09 - drugs that stimulate the function of the spinal cord mainly. Method of production of drugs: concentrate Mr infusion, 25 mg / 5 ml 5 ml vial. Indications for use drugs: erectile dysfunction (inability to blear and maintain an Upper Respiratory Quadrant necessary for sexual Transfer Dosing and Administration of drugs: use internally, regardless of the meal, at the beginning of treatment recommended dose is 10 mg tab. Oral gel, 50 mg / 5 g, 100 mg / 5 g to 5 g Four Times Each Day packet number 1, № 50. Method of production of drugs: cap.
ไม่มีความคิดเห็น:
แสดงความคิดเห็น